MD

Meena Dnyaneshwar Narhare

Active Director Director DIN 02857376
DIN 02857376 First appointment Feb 2010 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Meena Dnyaneshwar Narhare

Data last updated:

Meena Dnyaneshwar Narhare is a Director at Avista Healthcare Private Limited (since 2010). The company operates in Chemicals.

DIN 02857376
Primary Designation Director
Industry Chemicals
First Appointment 26 Feb 2010
Oldest Company Age 16 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avista Healthcare Private Limited U24232PN2010PTC135675
Director26 Feb 20102010Active

Board colleagues of Meena Dnyaneshwar Narhare

NameDINCompanyDesignation
Snehal Dnyaneshwar Narhare02857386Avista Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Avista Healthcare Private Limited
Premium access

Shareholding and investment profile for Meena Dnyaneshwar Narhare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meena Dnyaneshwar Narhare

Meena Dnyaneshwar Narhare currently holds 1 directorship: Avista Healthcare Private Limited (Director, since 26 Feb 2010).

Meena Dnyaneshwar Narhare was first appointed on 26 Feb 2010 as Director at Avista Healthcare Private Limited.

The current boards of Meena Dnyaneshwar Narhare's companies include Snehal Dnyaneshwar Narhare (Avista Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available